Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedA general NIH announcement about terminology during a website transition was added to the error page, and the site revision label changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, blocking access to the study record and related content.SummaryDifference18%

- Check39 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, indicating a newer version of the page content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new build of the page. No substantive content changes are reflected in this diff.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now states no longer looking for participants, indicating that recruitment is closed. Updated dates show primary completion on 2026-10-31 and study completion on 2028-02-29 to reflect the revised enrollment status.SummaryDifference4%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.